Atezolizumab in advanced non-small cell lung cancer

被引：7

作者：

Ilie, Marius ^{[1
,2
,3
,4
]}

Hofman, Paul ^{[1
,2
,3
,4
]}

机构：

[1] Univ Cote Azur, Univ Hosp Federat OncoAge, Lab Clin & Expt Pathol, Hop Pasteur, Nice, France

[2] Univ Cote Azur, Inst Res Canc & Ageing, Nice IR CAN, Inserm U1081, Nice, France

[3] UMR CNRS 7284, Nice, France

[4] Univ Cote Azur, Univ Hosp Federat OncoAge, Hosp Related Biobank BB 0033 00025, Hop Pasteur, Nice, France

来源：

JOURNAL OF THORACIC DISEASE | 2017年 / 9卷 / 10期

关键词：

PD-L1;

D O I：

10.21037/jtd.2017.09.73

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

引用

页码：3603 / 3606

页数：4

共 19 条

[1] Atezolizumab in advanced non-small-cell lung cancer [J].

Brower, Vicki .

LANCET ONCOLOGY, 2017, 18 (08) :E434-E434

[2]

Brunnstrom H, 2017, MOD PATHOL

[3] Quantification of PD-L1 and PD-1 expression on tumor and immune cells in non-small cell lung cancer (NSCLC) using non-enzymatic tissue dissociation and flow cytometry [J].

Chargin, Amanda ;

Morgan, Rian ;

Sundram, Uma ;

Shults, Keith ;

Tsay, Ellen L. ;

Ratti, Navneet ;

Patterson, Bruce K. .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2016, 65 (11) :1317-1323

[4] Atezolizumab in non-small cell lung cancer: the era of precision immuno-oncology [J].

Chow, James Chung Hang ;

Cheung, Ka Man ;

Cho, William Chi Shing .

ANNALS OF TRANSLATIONAL MEDICINE, 2017, 5 (12)

[5] Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial [J].

Fehrenbacher, Louis ;

Spira, Alexander ;

Ballinger, Marcus ;

Kowanetz, Marcin ;

Vansteenkiste, Johan ;

Mazieres, Julien ;

Park, Keunchil ;

Smith, David ;

Artal-Cortes, Angel ;

Lewanski, Conrad ;

Braiteh, Fadi ;

Waterkamp, Daniel ;

He, Pei ;

Zou, Wei ;

Chen, Daniel S. ;

Yi, Jing ;

Sandler, Alan ;

Rittmeyer, Achim .

LANCET, 2016, 387 (10030) :1837-1846

[6] Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update [J].

Hanna, Nasser ;

Johnson, David ;

Temin, Sarah ;

Baker, Sherman, Jr. ;

Brahmer, Julie ;

Ellis, Peter M. ;

Giaccone, Giuseppe ;

Hesketh, Paul J. ;

Jaiyesimi, Ishmael ;

Leighl, Natasha B. ;

Riely, Gregory J. ;

Schiller, Joan H. ;

Schneider, Bryan J. ;

Smith, Thomas J. ;

Tashbar, Joan ;

Biermann, William A. ;

Masters, Gregory .

JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (30) :3484-+

[7] Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial [J].

Herbst, Roy S. ;

Baas, Paul ;

Kim, Dong-Wan ;

Felip, Enriqueta ;

Perez-Gracia, Jose L. ;

Han, Ji-Youn ;

Molina, Julian ;

Kim, Joo-Hang ;

Arvis, Catherine Dubos ;

Ahn, Myung-Ju ;

Majem, Margarita ;

Fidler, Mary J. ;

de Castro, Gilberto, Jr. ;

Garrido, Marcelo ;

Lubiniecki, Gregory M. ;

Shentu, Yue ;

Im, Ellie ;

Dolled-Filhart, Marisa ;

Garon, Edward B. .

LANCET, 2016, 387 (10027) :1540-1550

[8] Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients [J].

Herbst, Roy S. ;

Soria, Jean-Charles ;

Kowanetz, Marcin ;

Fine, Gregg D. ;

Hamid, Omid ;

Gordon, Michael S. ;

Sosman, Jeffery A. ;

McDermott, David F. ;

Powderly, John D. ;

Gettinger, Scott N. ;

Kohrt, Holbrook E. K. ;

Horn, Leora ;

Lawrence, Donald P. ;

Rost, Sandra ;

Leabman, Maya ;

Xiao, Yuanyuan ;

Mokatrin, Ahmad ;

Koeppen, Hartmut ;

Hegde, Priti S. ;

Mellman, Ira ;

Chen, Daniel S. ;

Hodi, F. Stephen .

NATURE, 2014, 515 (7528) :563-+

[9] PD-L1 Immunohistochemistry Assays for Lung Cancer: Results from Phase 1 of the Blueprint PD-L1 IHC Assay Comparison Project [J].

Hirsch, Fred R. ;

McElhinny, Abigail ;

Stanforth, Dave ;

Ranger-Moore, James ;

Jansson, Malinka ;

Kulangara, Karina ;

Richardson, William ;

Towne, Penny ;

Hanks, Debra ;

Vennapusa, Bharathi ;

Mistry, Amita ;

Kalamegham, Rasika ;

Averbuch, Steve ;

Novotny, James ;

Rubin, Eric ;

Emancipator, Kenneth ;

McCaffery, Ian ;

Williams, J. Andrew ;

Walker, Jill ;

Longshore, John ;

Tsao, Ming Sound ;

Kerr, Keith M. .

JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (02) :208-222

[10] Comparative study of the PD-L1 status between surgically resected specimens and matched biopsies of NSCLC patients reveal major discordances: a potential issue for anti-PD-L1 therapeutic strategies [J].

Ilie, M. ;

Long-Mira, E. ;

Bence, C. ;

Butori, C. ;

Lassalle, S. ;

Bouhlel, L. ;

Fazzalari, L. ;

Zahaf, K. ;

Lalvee, S. ;

Washetine, K. ;

Mouroux, J. ;

Venissac, N. ;

Poudenx, M. ;

Otto, J. ;

Sabourin, J. C. ;

Marquette, C. H. ;

Hofman, V. ;

Hofman, P. .

ANNALS OF ONCOLOGY, 2016, 27 (01) :147-153

← 1 2 →